Acute kidney injury from SGLT2 inhibitors: potential mechanisms
Nature Reviews Nephrology 12, 711 (2016).
doi:10.1038/nrneph.2016.159
Authors: Kai Hahn, A. Ahsan Ejaz, Mehmet Kanbay, Miguel A. Lanaspa & Richard J. Johnson
SGLT2 inhibitors have shown great promise in the management of diabetes mellitus and the prevention of cardiovascular complications, but increasing evidence suggests that their use can be associated with an increased risk of acute kidney injury. Insights into the mechanisms involved might help to identify individuals who are at risk of renal injury.
Source: Nature Reviews Nephrology - Category: Urology & Nephrology Authors: Kai Hahn A. Ahsan Ejaz Mehmet Kanbay Miguel A. Lanaspa Richard J. Johnson Tags: Comment Source Type: research
More News: Cardiology | Cardiovascular | Diabetes | Diabetes Mellitus | Endocrinology | Heart | SGLT2 Inhibitors | Urology & Nephrology